Role of Pin1 and Presenilin-1 Interaction In Vivo
About the Research Project
Program
Award Type
Pilot
Award Amount
$150,000
Active Dates
April 01, 2007 - March 31, 2010
Grant ID
A2007019
Goals
Our hypothesis in this proposal is that Pin1 might also regulate the function of presenilin 1, an essential component of the enzyme responsible for ABeta production, and that this regulation might be disrupted by some Alzheimer’s mutations in presenilin 1. To test this hypothesis, we will determine whether Pin1 regulates presenilin 1 structure in a test tube, whether manipulating Pin1 function affects PS1 activity in cell culture and animal models, and whether this Pin1-dependent regulation is disrupted by presenilin 1 mutations.
Summary
Alzheimer’s disease is the most common form of dementia and its pathological hallmarks are tangles made of a protein called tau and plaques comprising small peptides called ABeta peptides generated from its precursor protein called APP. We have recently identified a new enzyme, Pin1 that regulates the structure and function of certain proteins such as tau and APP. Moreover, Pin1 is pivotal for protecting against tangle formation, ABeta accumulation and neurodegeneration. Notably, Pin1 is inhibited by various mechanisms in Alzheimer’s patients. These results suggest that Pin1 deregulation is an important factor in Alzheimer’s development, although its molecular targets and mechanisms are not fully elucidated. Our hypothesis in this proposal is that Pin1 might also regulate the function of presenilin 1, an essential component of the enzyme responsible for ABeta production, and that this regulation might be disrupted by some Alzheimer’s mutations in presenilin 1. To test this hypothesis, we will determine whether Pin1 regulates presenilin 1 structure in a test tube, whether manipulating Pin1 function affects PS1 activity in cell culture and animal models, and whether this Pin1-dependent regulation is disrupted by presenilin 1 mutations. These studies would provide new insight into Alzheimer’s development and might have important therapeutic implication.
Related Grants
Alzheimer's Disease Research
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Alzheimer's Disease Research
Does Alzheimer’s Disease Accelerate Brain Aging?
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
MaríA Llorens-Martín, PhD
Current Organization
Spanish National Research Council
Does Alzheimer’s Disease Accelerate Brain Aging?
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
MaríA Llorens-Martín, PhD
Current Organization
Spanish National Research Council
Alzheimer's Disease Research
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University